From 2025 to 2035, the probiotic ingredients market is expected to experience significant growth mostly because people are more aware of different benefits of probiotic ingredients in gut health, immune system, and microbiome-based wellness solutions.
The growing desire for functional foods and dietary supplements is causing an increase in the demand for clinically tested probiotic strains, with producers adding advanced formulations, and technologies that increase stability. Accepting probiotics in the mainstream, they also go beyond their usual application in dairy and supplements transforming into other areas such as sports nutrition, infant health, beauty, and mental well-being.
The increasing acknowledgment of gut microbiome’s role in general well-being is one of the crucial factors that bolstered the market development. The consumers’ trend for probiotics as an alternative way from taking medication to controlling digestive, immune, metabolic, and cognitive functions is the key factor.
The prevalence of digestive disorders, gut problems caused by lifestyle, and stress-related health problems led to the demand for certain probiotics which have scientific proof of their results. This resulted in a high demand for psychobiotics for mental health, synbiotics (which are probiotics and prebiotics together), and postbiotics (which are probiotics metabolites), adding more varieties to the market.
The companies are notably dedicated to innovations for making probiotics more stable, resilient, and focused on the affected areas. The arrival of spore-forming probiotics (Bacillus strains) has opened the gate for adding probiotics to shelf-stable food and drinks.
Furthermore, microencapsulation technology is enabling the use of probiotics in baked goods, chocolates, and ready-to-eat meals by giving better viability. Companies are looking to increase their sales and become sector leaders by introducing probiotic gummies, effervescent powders, and oral dissolving strips as the more promising and convenient formats.
The situation is getting more tense therefore, the market is witnessing remarkably high competition with some major players such as Chr. Hansen, DuPont (IFF), Kerry Group, and BioGaia taking the lead. This group of companies by venturing through merges, acquisitions, and partnerships are looking to build an army of their global empire.
The recent Chr. Hansen-Novozymes merger is one of the best examples of strategic initiatives to increase bio solutions and probiotic innovation. Meanwhile, the local players like Lallemand and Probi AB are directly involved in the expansion of strain portfolios and distribution networks, concentrating on the niche market with the sale of pet probiotics and medical probiotics.
| Attributes | Description |
|---|---|
| Estimated Global Industry Size (2025 E) | USD 8 million |
| Projected Global Industry Value (2035 F) | USD 12 million |
| Value-based CAGR (2025 to 2035) | 3.3% |
The forthcoming decade will see an advancement in the field of personalized probiotics, AI in microbiome research, and the setting of common regulations. Government and health organizations are backing clinical-backed probiotic formulations that are trusted more by consumers leading to the growth of the market.
The rising shift of probiotics from general wellness to therapeutic applications has also helped the market gain continually according to research advancements, versatile applications, and high consumer need.
Explore FMI!
Book a free demo
The below table presents a comparative assessment of the variation in CAGR over six months for the base year (2024) and current year (2025) for the global industry. This analysis reveals crucial shifts in market performance and indicates revenue realization patterns, thus providing stakeholders with a better vision of the growth trajectory over the year. The first half of the year, or H1, spans from January to June. The second half, H2, includes the months from July to December.
| Particular | Value CAGR |
|---|---|
| H1(2024 to 2034) | 6.9% |
| H2(2024 to 2034) | 7.3% |
| H1(2025 to 2035) | 7.2% |
| H2(2025 to 2035) | 7.5% |
The global industry's predicted compound annual growth rate (CAGR) over a semi-annual period from 2025 to 2035 is shown in the above table. The business is anticipated to grow at a CAGR of 6.9% in the first half (H1) of 2024 and then slightly faster at 7.3% in the second half (H2) of the same year.
The CAGR is anticipated to decrease somewhat to 7.2% in the first half of 2025 and continues to grow at 7.5% in the second half. The industry saw a decline of 35 basis points in the first half (H1 2025) and an increase of 46 basis points in the second half (H2 2025).
Expansion of Psychobiotics for Mental Well-being
The deepening knowledge of the gut-brain axis has introduced psychobiotics, which are the mental health and cognitive function. Research studies reveal that some Lactobacillus and Bifidobacterium strains help the production of neurotransmitters like serotonin and gamma-aminobutyric acid (GABA). GABA is a vital regulator of mood.
Consumers are showing a growing trend in probiotic supplements that are related specifically to stress management, anxiety reduction, and sleep quality. This issue is being driven by the increase and popularity of interventions that do not require pills for a balanced mind.
Companies like Chr. Hansen and DuPont (IFF) have committed themselves to the clinical trials to confirm the claims associated with psychobiotic supplements. For their part, the brands are attaching psychobiotics to functional items like foods, drinks, and dietary supplements which are proposed to contribute to the enhancement of emotional resilience and cognitive clarity.
Growing Demand for Next-Generation Spore-Forming Probiotics
Stored in a refrigerator, traditional probiotic strains such as Lactobacillus and Bifidobacterium tend to perish in severe conditions such as high temperature and acidity. Nonetheless, probiotics that are spore-forming, particularly Bacillus coagulans and Bacillus subtilis, are becoming expected due to their ability to withstand high temperatures, acidic conditions, and long shelf life.
These strains are now being positioned as ideal materials for functional beverages, dietary supplements, and dry food applications. The sports nutrition and pharmaceuticals sectors are mainly pushing the interest in probiotics based on spores as they had been backed up by studies that display their effectiveness not only in the intestines, but also in the body in general, as they regulate immunity and promote digestion.
Major companies like Kerry Group (GanedenBC30®) and Sabinsa Corporation are the frontrunners of the innovation race in this territory, driven by extensive clinical studies and the finding that spore-forming probiotics help restore the gut flora and immunity.
Integration of Probiotics in Sports Performance & Recovery
Athletes and those who are fitness oriented are beginning to appreciate the impact of gut microbiota in performance, endurance, and muscle recovery. The studies found that probiotics improve nutrient absorption, control inflammation, and support the immune system, and thus they are an important tool in sports nutrition applications.
Probiotic strains like Lactobacillus plantarum and Bacillus coagulans are now being incorporated into protein powders, energy bars, sports drinks, and post-workout recovery formulas. The interest of the sports sector in probiotics is seen in their capability to lessen oxidative stress, which is induced by exercise, and muscle damage.
Probi AB and Lallemand Inc. have been the key drivers of research into probiotics concerning the recuperation of athletes. As the industry flourishes, the companies are in the process of launching multi-strain mixtures focused solely on endurance athletes, which correlates with a popular, new trend in sports nutrition that enhances the gut microbiome.
Synbiotic Formulations Driving New Product Innovations
Synbiotics, combinations of probiotics and prebiotics, are changing the way we think about gut health formulations. They improve probiotic survival and efficacy by acting together. While standalone probiotics focus on bacteria only, synbiotics feed the good bacteria directly by providing nutrients through prebiotic fibers such as inulin, fructooligosaccharides (FOS), and galactooligosaccharides (GOS).
The consumer's wish list includes such products that work optimally with pre- and probiotics and at the same time improve their digestive health. Among the major players developing synbiotic products for immunity, metabolic health, and weight loss are Chr. Hansen, IFF (Danisco), and Yakult.
The trend transcends just supplements into functional dairy, plant-based drinks, and meal replacements, which brands feed specific populations, like children, and the elderly, and the athletes with. The scientific acceptance of synbiotics is predicted to speed along their adoption in the fields of both clinical and consumer health.
Expansion of Infant and Early Life Probiotics
An increasing body of research confirming the part that gut bacteria play in infant health has resulted in a similar growth of demand for probiotics for infants and toddlers, that have been claimed to be clinically validated. Parents resort to the natural approach and gut-friendly methods instead of drugs for the control of colic, digestive discomfort, and improving the immune system.
Probiotic strains such as Bifidobacterium breve, Bifidobacterium infantis, and Lactobacillus rhamnosus GG are famous for their therapeutic effects on colic, the strengthening of the immune system, and an increase in gut microbiome diversity during early life.
Infant formula manufacturers are incorporating probiotic strains in baby formulas and liquid drops such as Nestlé (Gerber), Danone (Aptamil), and Morinaga Milk Industry. The maternal probiotics that get the most attention are those that are,vital to a healthy pregnancy, help babies avoid allergies, and females by increasing the proliferation of beneficial gut flora.
Diversification of Probiotic Delivery Formats
Consumers tend to turn away from the conventional formats of probiotics consisting of pills, powders, and fermented dairy products. This has opened up the avenue to new delivery formats that are more convenient and which compliance is higher. The New schedule of probiotic formats like gummies, effervescent powders, oral dissolving strips, chocolates, and probiotic-infused snacks which are found in supermarkets is on the rise.
Their attraction lies in their taste, ease of consumption, and the fact that they tend to contain the probiotic live cells within them that are more stable. Companies like BioGaia, DSM, and Probiotical are bringing in probiotic chewables and functional confectioneries such as gummies targeted at both adults and children.
In addition, the use of microencapsulation technology has helped the goods producers to come up with baked products, breakfast cereals, and shelf-stable snacks with probiotics included without compromising the viability of the probiotics. The shift to a more enjoyable way of taking probiotics is anticipated to increase market size, especially in the gut health and immune markets.
Between 2020 and 2024, the probiotic ingredient market is on a stable upswing that is possessed by the growing interest of the consumers in the gut health, immunity, and digestive wellness areas. The pandemic of COVID-19 turned into a demand booster as the consumers were searching for products that support the microbiome of the body and at the same time give a boost to the immunity.
The increase in functional foods, dietary supplements, and pharma applications has brought about the highlight in the sales and the major players are working on strain development and clinical validation. The passage from science to technology and injection of mechanical improvements in areas of health, sports, and mindset will dictate the market from 2025 to 2035 where demand will definitely be at the peak. Serious advancement will be due to technologies, scientific improvements, and regulatory approvals, and this way the market will stay strong and the distribution will be wider in global areas.
The international probiotic ingredients market consists of the moderate concentration with the Tier 1, Tier 2, and Tier 3 players being very active in competing on the issues of innovation, product efficacy, and market reach.
As the Tier 1 players namely Chr. Hansen, DuPont (IFF), Kerry Group, and BioGaia control the market with their power, and thanks to their resources, they can acquire more companies, drive the R&D agenda and build up extensive distribution networks.
These companies are heavy spenders in the areas of clinical trials, following regulations, and new strain development, so their probiotic ingredients are the most researched and thus the most rated.CHR. Hansen’s merger and acquisition of Novozymes are also the cases in point to mention.
Firms like Lallemand, Probi AB, and Morinaga Milk Industry, are Tier 2 companies and are supporting different regions' probiotic solutions while becoming more global. They dedicate themselves to custom formulations, symbiotic technologies, and stability-enhancing technology, which is what they offer to the industry to make probiotic products more accessible in functional food, infant nutrition, and pharma applications.
Tier 3 justifies the absence of the bigger players, as Deerland Probiotics & Enzymes and Synbio Tech are more of niche companies specially dedicated to the spore-forming strains and the gut health-focused solutions. These businesses are for big, specific consumer needs, such as beauty probiotics, sports performance probiotics, and psychobiotics.
The industry develops through the accomplishments made in cross-industrial collaborations, the introduction of delivery formats, and the scientific breakthroughs that further the competition, through providing a variety of solutions that address the growing consumer demands.
The following table shows the estimated growth rates of the top three countries. USA, China and Germany are set to exhibit high consumption, and CAGRs of 3.8%, 6.3% and 2.5% respectively, through 2035.
| Country | CAGR 2025 to 2035 |
|---|---|
| United States | 3.8% |
| China | 6.3% |
| Germany | 2.5% |
China, the main consumer of probiotic ingredients, is a market backed by Traditional Chinese Medicine (TCM). The combination of probiotics and the herbal formula is a trend of development as brands take the opportunity of the peoples belief in the holistic healing and gut balance. Manufacturer makes the probiotic blends by adding TCM herbs, like ginseng, astragalus, goji berries, etc. with the benefits of immune, digestive, and energy levels.
All the major companies like By-Health and Inner Mongolia Yili Industrial Group are the ones that are coming up with different kinds of fermented herbal probiotic drinks and capsules. Moreover, the need for probiotics that are personal based on TCM diagnostics is also growing.
As the consumers want functional products that contain only natural ingredients and not many additives, and they prefer the products that promote digestive health, so this fusion of probiotics and ancient medicines is the key to expanding the market.
The USA probiotic market is making a transition from just being in a supplement and dairy category to mainstream food due to the active and health-conscious segment of the population. Consumers are supporting cereals, granola bars, nut butters, and condiments along with the probiotics that gut health benefits in the most convenient formats.
The biggest food companies such as Kellogg's, Nestlé, and General Mills are dealing with spore-forming probiotics which survive the production and storage of these processed foods. The functional probiotics snacks like probiotic popcorn, chips, and chocolate bars, are getting acknowledged as a significant sector.
The main reason that this trend emerges is the increment in the public's understanding of the connection between gut and immune problems; people prefer to eat immune-boosting foods without changing their diets. As digestive health is now a commonly discussed topic, the integration of probiotics into packaged foods is almost routine, and lines between supplements and standard nutrition are blurred.
Germany, which is famous for its strong pharmaceutical and functional food markets, is seeing a rise in probiotics often used for gut inflammation and microbiome-depression disorders. Patients and health professionals are looking for doctor-approved probiotic strains for conditions such as Irritable Bowel Syndrome (IBS), Crohn's disease, and ulcerative colitis.
The pharmaceutical field is becoming the leader in this sphere while SymbioPharm, BioGaia, and Dr.Wolz are the names of the companies that are engaged in making the probiotics that are focused on lowering the intestinal inflammation and on the restoration of the microbiome.
The German consumer's age of scientific trust prevails as they choose the probiotics that have medical backing and get a regulatory approval statement. The projection for the prescription and over-the-counter gut-health medications with probiotics is that they will become more integrated, because the physicians are getting on board with the microbiome treatments for digestive disorders more often.
| Segment | Value Share (2025) |
|---|---|
| Food and Beverage (End Use Application) | 42.7% |
The bacterial probiotic ingredients hold the major market share in the global probiotic ingredients market, as currently, the clinically validated strains have almost universal application in the food, pharmaceutical, and nutraceutical sectors. There are strains like Lactobacillus, Bifidobacterium, and Bacillus which are currently on demand because of their extensive backing from research, their stability, and the various associated health benefits.
These bacteria are being increasingly used in health-intent stomach products, immune-boosting supplements, and functional food products, which in turn serve a growing number of consumers who are looking for scientifically verified solutions.
The strengthening of the strain-specific probiotic market is due to strains proved to treat IBS and boost metabolic and immune functions and their alloy with consumers' trust will lead to further investment from the major players like Chr. Hansen, DuPont (IFF), and Kerry Group. With the appearance of new bacterial strains that are identified and optimized for better survival rates and specific health advantages, the market is primed for both strong growth and development.
The food and beverage industry is at the forefront driving the requisition for probiotic ingredients as people look for gut-friendly choices in their daily diet. The transition of probiotics from just being used in the traditional yogurts and fermented drinks to baked goods, plant-based beverages, dairy alternatives, and functional snacks, all the way to the current state, where it is used everywhere the consumer sees fit is helping with pretty much all of it.
Brands like Nestlé, Danone, and PepsiCo are the ones that are taking the lead in this sector, introducing the products that are enriched in probiotics and approaching issues like digestive health, immunity, and overall well-being. The proliferation of shelf-stable probiotics variants like spore-forming strains that go through processing unscathed has considerably broadened the probiotic use in ready-to-eat and convenience foods.
With consumers increasing their health and nutrition consciousness without altering their eating habits food manufacturers are now promoting probiotic fortification as a premium product differentiator, and as a result, they have gained significant sales and market penetration across the global retail channels.
The probiotic ingredients business is experiencing stiff rivalry as the producers are utilizing tactical creativity, merger and acquisition, and exclusive product launches to remain the leaders. Companies like Chr. Hansen, DuPont (IFF), Kerry Group, and BioGaia are emphasizing on the development of strains that have been clinically proven to work to meet the increased request for personalized and functional probiotics.
Firms are diversifying to non-dairy, sports nutrition, and gut-brain health types of applications in line with the changing tastes and preferences of consumers. The formation of mergers and acquisitions that impact the market such as the IFF merger with the DuPont Nutrition and Biosciences and the partnership of Chr. Hansen with Novozymes that foster the biotech knowledge are the main players.
Further, enterprises are employing microencapsulation technology for the first time to maintain consistency in the probiotic delivery system in convenience foods and beverages. Manufacturers are fielding more and more products, gaining a strategic upper hand through increased R&D, and more prominent distribution networks.
The global probiotic ingredients market is valued at USD 5,769 million in 2023.
The United States is anticipated to be the leading consumer of probiotic ingredients, with a projected valuation of USD 1,288.7 million by 2033.
With a projected CAGR of 5.6% through 2033, the bacterial probiotic ingredients segment is projected to emerge as the top product type.
The growing consumer preference for functional foods and dietary supplements promoting gut health is the current market trend.
Chr. Hansen A/S, Danisco A/S, Lallemand, Inc., LeSaffre, S.A., and Probi AB are the key players operating in the probiotic ingredients market.
Market Outlook of Omega-3 Pet Supplement by Pet, Type, Form, Application and Other Types Through 2035
Extra Neutral Alcohol (ENA) Market Analysis – Growth, Applications & Outlook 2025-2035
Analysis and Growth Projections for Beverage Flavoring Agent
Plant-Based Collagen Market Analysis by Sources, Form and End-use Industry Through 2035
Analysis and Growth Projections for Fish Gelatin Market
Analysis and Growth Projections for Brown Rice Market
Probiotic Ingredients Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
